This post was originally published on Sherwood News.
Strive has already been probed over the timing of its GLP-1 compounding. Now, Arizona regulators are looking into complaints about ketamine misuse and improper distribution of prescription drugs.
Before Hims’ GLP-1 pill fallout, its pharmacy partner was already drawing scrutiny from state regulators
Leave a Reply